Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

For the purpose of exploring the development, pharmacology and clinical trial program related to dulaglutide, we conducted a nonsystematic review of dulaglutide, focusing on the AWARD (Assessment of Weekly Administration of LY2189265 [dulaglutide] in Diabetes Assessment) program of randomized, phase...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina V. Shestakova, Ekaterina A. Yudovich
Format: Article
Language:English
Published: Endocrinology Research Centre 2017-08-01
Series:Сахарный диабет
Subjects:
diabetes mellitus type 2, dulaglutide, glucagon-like peptide 1, hypoglycemic agents
Online Access:https://www.dia-endojournals.ru/jour/article/view/8347
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items